We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Impax investing

17 October 2017 By Kate Duguid

The merger of Amneal with Impax, worth some $9 bln in combined enterprise value, brings scale, savings and a bigger business for a respected CEO. But the larger firm is private, its owners are selling down, and there’s a wacky tax element. No wonder Impax owners aren’t loving it.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)